Maze Therapeutics, Inc.
MAZE · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary
4 Item 1A. Risk Factors 26 Item 1B. Unresolved Staff Comments 75 Item 1C. Cybersecurity 75 Item 2. Properties 76 Item 3. Legal Proceedings 76 Item 4. Mine Safety Disclosures 76 PART II 77 Item 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 77 Item 6. [Reserved] 77 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 78 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 90 I...
Next Earnings
Q2 FY2026 — expected 2026-09-07
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | MAZE | discussed_in_filing Cybersecurity | |
| topic_mention | MAZE | discussed_in_filing Cybersecurity | |
| topic_mention | MAZE | discussed_in_filing Cybersecurity | |
| topic_mention | MAZE | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-25 | 2025-12-31 | 0001193125-26-122778 | EDGAR | 101K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047208 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269689 | EDGAR | 68K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107306 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071375 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-25 | 0001193125-26-122774 | EDGAR | 3K words |
| 2026-02-04 | 0001193125-26-037747 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269624 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230926 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200760 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193353 | EDGAR | — |
| 2025-08-12 | 0000950170-25-107299 | EDGAR | — |
| 2025-05-14 | 0000950170-25-071357 | EDGAR | — |
| 2025-03-31 | 0000950170-25-047207 | EDGAR | — |
18 total filings indexed. 4 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001842295 |
| Ticker | MAZE |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 6263fa253d689f820e24c988299c6dc9e1ae89e2cc9b13d6de03d00e06aab3e6
parent: aace4fb902931b57beb685dc4f35da33a8c7da5e00c06e09a36bdda9c500ffd7
content hash: d675805fbd1c14ef07c9442feb3b3258dfa1dbf42c3753c0886f6f3e5ccfa0aa
signed: 2026-04-13T04:46:10.692Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf